Dermatologicals

Western Europe is the third biggest region for dermatologicals. Germany is the largest market, followed by Italy. The category has reached ts maturity in several WE markets, but, due to, constantly growing incidence of allergies, climate changes and…

Hair weakens and becomes vulnerable to shedding due to reasons like seasonality (seasonal transitions), stress, hormonal changes and thermal applications. For this reason, hair loss treatments tends to see increases in demand in spring and autumn,…

Demand for hair loss treatments is declining in 2023 following strong growth in recent years as COVID-19 and subsequent inflationary pressure boosted prevalence of hair loss due to stress and anxiety. Although the latter remains an overbearing issue…

In general, dermatologicals was largely unaffected by the Coronavirus (COVID-19) pandemic. Most categories of dermatologicals continued to see retail volume growth in 2020, many of them at a similar rate to 2019. There are a number of underlying…

Dermatologicals continues its positive development in 2023, although value growth has subsided slightly compared to 2022 levels. On balance, value sales are still stronger than the pre-pandemic era when demand dropped amid social distancing and home…

Dermatologicals experienced a modest decline in overall constant value terms in 2023, although performance varied considerably according to subcategory. One notable development was the buoyant demand for antiparasitics/lice treatments, continuing the…

After recording strong growth in 2022, sales of many dermatologicals in 2023 are weakening. Declining disposable incomes due to elevated inflation and higher interest rates are eroding the interest of Spaniards in spending on perceived non-essential…

Dermatologicals is set to register positive growth in current value and retail volume terms in 2023. With the WHO declaring the pandemic to be over in May 2023, there has been an increase in socialisation and physical contact between people which has…

Dermatologicals continued to record positive value growth in current price terms over the course of 2023 as the essential nature of many of these products for those experiencing moderate skin health issues ensured that demand remained relatively…

Dermatologicals is seeing steady single-digit growth in current value terms in 2023. Two of the most important product areas, topical antifungals and vaginal antifungals, are both seeing moderate growth in 2023, although this is largely due to…